These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25858589)

  • 1. Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.
    Terrazzino S; Argyriou AA; Cargnin S; Antonacopoulou AG; Briani C; Bruna J; Velasco R; Alberti P; Campagnolo M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Kalofonos HP; Canonico PL; Genazzani AA; Cavaletti G
    J Peripher Nerv Syst; 2015 Mar; 20(1):15-23. PubMed ID: 25858589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
    Argyriou AA; Cavaletti G; Antonacopoulou A; Genazzani AA; Briani C; Bruna J; Terrazzino S; Velasco R; Alberti P; Campagnolo M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Psaromyalou A; Angelopoulou A; Kalofonos HP
    Cancer; 2013 Oct; 119(19):3570-7. PubMed ID: 23821303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.
    Won HH; Lee J; Park JO; Park YS; Lim HY; Kang WK; Kim JW; Lee SY; Park SH
    Cancer; 2012 Jun; 118(11):2828-36. PubMed ID: 22020760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study.
    Briani C; Argyriou AA; Izquierdo C; Velasco R; Campagnolo M; Alberti P; Frigeni B; Cacciavillani M; Bergamo F; Cortinovis D; Cazzaniga M; Bruna J; Cavaletti G; Kalofonos HP
    J Peripher Nerv Syst; 2014 Dec; 19(4):299-306. PubMed ID: 25582667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer.
    Oguri T; Mitsuma A; Inada-Inoue M; Morita S; Shibata T; Shimokata T; Sugishita M; Nakayama G; Uehara K; Hasegawa Y; Ando Y
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):475-81. PubMed ID: 23547850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin-induced peripheral neurotoxicity.
    Argyriou AA; Kalofonou F; Litsardopoulos P; Anastopoulou GG; Kalofonos HP
    J Peripher Nerv Syst; 2021 Mar; 26(1):43-48. PubMed ID: 33345432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.
    Velasco R; Bruna J; Briani C; Argyriou AA; Cavaletti G; Alberti P; Frigeni B; Cacciavillani M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Kalofonos HP
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):392-8. PubMed ID: 23813745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study.
    Argyriou AA; Briani C; Cavaletti G; Bruna J; Alberti P; Velasco R; Lonardi S; Cortinovis D; Cazzaniga M; Campagnolo M; Santos C; Kalofonos HP
    Eur J Neurol; 2013 May; 20(5):788-94. PubMed ID: 23252594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin scale and National Cancer Institute-Common Toxicity Criteria in the assessment of chemotherapy-induced peripheral neuropathy.
    Kautio AL; Haanpää M; Kautiainen H; Leminen A; Kalso E; Saarto T
    Anticancer Res; 2011 Oct; 31(10):3493-6. PubMed ID: 21965767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.
    Sereno M; Gutiérrez-Gutiérrez G; Rubio JM; Apellániz-Ruiz M; Sánchez-Barroso L; Casado E; Falagan S; López-Gómez M; Merino M; Gómez-Raposo C; Rodriguez-Salas N; Tébar FZ; Rodríguez-Antona C
    BMC Cancer; 2017 Jan; 17(1):63. PubMed ID: 28103821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity.
    Argyriou AA; Antonacopoulou AG; Alberti P; Briani C; Bruna J; Velasco R; Anastopoulou GG; Park SB; Cavaletti G; Kalofonos HP
    J Peripher Nerv Syst; 2019 Dec; 24(4):298-303. PubMed ID: 31486252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin-induced peripheral neuropathy in Taiwanese patients with colorectal cancer.
    Hsu SY; Huang WS; Lee SH; Chu TP; Lin YC; Lu CH; Beaton RD; Jane SW
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12976. PubMed ID: 30536809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real world, open label experience with lacosamide against acute painful oxaliplatin-induced peripheral neurotoxicity.
    Argyriou AA; Kalofonou F; Litsardopoulos P; Anastopoulou GG; Psimaras D; Bruna J; Kalofonos HP
    J Peripher Nerv Syst; 2020 Jun; 25(2):178-183. PubMed ID: 32277545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?
    Antonacopoulou AG; Argyriou AA; Scopa CD; Kottorou A; Kominea A; Peroukides S; Kalofonos HP
    Eur J Neurol; 2010 Jul; 17(7):963-8. PubMed ID: 20192979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in cyclin H gene are associated with oxaliplatin-induced acute peripheral neuropathy in South Indian digestive tract cancer patients.
    Palugulla S; Devaraju P; Kayal S; Narayan SK; Mathaiyan J
    Cancer Chemother Pharmacol; 2018 Sep; 82(3):421-428. PubMed ID: 29936608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
    Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
    Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
    Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP
    Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and electrophysiological studies of oxaliplatin-induced peripheral neuropathy].
    Liu LZ; Wu JY; Wu ZY; Chen ZH; Ling L; Sun B; Li YF; Huang XS
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1021-5. PubMed ID: 27055794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin-induced sensory neuropathy in gastrointestinal cancers.
    Xu XT; Dai ZH; Xu Q; Qiao YQ; Gu Y; Nie F; Zhu MM; Tong JL; Ran ZH
    J Dig Dis; 2013 Jun; 14(6):288-98. PubMed ID: 23432969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.
    Leandro-García LJ; Inglada-Pérez L; Pita G; Hjerpe E; Leskelä S; Jara C; Mielgo X; González-Neira A; Robledo M; Avall-Lundqvist E; Gréen H; Rodríguez-Antona C
    J Med Genet; 2013 Sep; 50(9):599-605. PubMed ID: 23776197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.